Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship

Jakub Mesinovic,1 Ayse Zengin,1 Barbora De Courten,2 Peter R Ebeling,1,3 David Scott,1,31Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Melbourne, VIC, Australia; 2Monash Centre for Health R...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	type 2 diabetes mellitus sarcopenia metabolic health muscle health obesity. Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/8e924688b5b94b09b124da5788b14033
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8e924688b5b94b09b124da5788b14033
record_format	dspace
spelling	oai:doaj.org-article:8e924688b5b94b09b124da5788b140332021-12-02T03:08:22ZSarcopenia and type 2 diabetes mellitus: a bidirectional relationship1178-7007https://doaj.org/article/8e924688b5b94b09b124da5788b140332019-07-01T00:00:00Zhttps://www.dovepress.com/sarcopenia-and-type-2-diabetes-mellitus-a-bidirectional-relationship-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Jakub Mesinovic,1 Ayse Zengin,1 Barbora De Courten,2 Peter R Ebeling,1,3 David Scott,1,31Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Melbourne, VIC, Australia; 2Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Melbourne, VIC, Australia; 3Australian Institute for Musculoskeletal Science (AIMSS), Department of Medicine - Western Health, Melbourne Medical School, The University of Melbourne, St Albans, Melbourne, VIC, AustraliaAbstract: The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter- and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.Keywords: type 2 diabetes mellitus, sarcopenia, metabolic health, muscle health, obesityMesinovic JZengin ADe Courten BEbeling PRScott DDove Medical Pressarticletype 2 diabetes mellitussarcopeniametabolic healthmuscle healthobesity.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1057-1072 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	type 2 diabetes mellitus sarcopenia metabolic health muscle health obesity. Specialties of internal medicine RC581-951
spellingShingle	type 2 diabetes mellitus sarcopenia metabolic health muscle health obesity. Specialties of internal medicine RC581-951 Mesinovic J Zengin A De Courten B Ebeling PR Scott D Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
description	Jakub Mesinovic,1 Ayse Zengin,1 Barbora De Courten,2 Peter R Ebeling,1,3 David Scott,1,31Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Melbourne, VIC, Australia; 2Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Melbourne, VIC, Australia; 3Australian Institute for Musculoskeletal Science (AIMSS), Department of Medicine - Western Health, Melbourne Medical School, The University of Melbourne, St Albans, Melbourne, VIC, AustraliaAbstract: The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter- and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.Keywords: type 2 diabetes mellitus, sarcopenia, metabolic health, muscle health, obesity
format	article
author	Mesinovic J Zengin A De Courten B Ebeling PR Scott D
author_facet	Mesinovic J Zengin A De Courten B Ebeling PR Scott D
author_sort	Mesinovic J
title	Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
title_short	Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
title_full	Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
title_fullStr	Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
title_full_unstemmed	Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
title_sort	sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/8e924688b5b94b09b124da5788b14033
work_keys_str_mv	AT mesinovicj sarcopeniaandtype2diabetesmellitusabidirectionalrelationship AT zengina sarcopeniaandtype2diabetesmellitusabidirectionalrelationship AT decourtenb sarcopeniaandtype2diabetesmellitusabidirectionalrelationship AT ebelingpr sarcopeniaandtype2diabetesmellitusabidirectionalrelationship AT scottd sarcopeniaandtype2diabetesmellitusabidirectionalrelationship
_version_	1718401930787553280

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship

Ejemplares similares